
70% Remission for Postpartum Depression? The Psychedelic Breakthrough
4/30/2026
0:00
35:54
Postpartum depression treatment advances with psychedelic therapy. Greg Mayes of Reunion Neuroscience discusses luvesilocin drug development. This episode explores how shorter-acting psilocybin analogs offer new hope for mothers. Greg highlights the success of the RECONNECT study and the path to FDA breakthrough designation.
More episodes from "Power to the Patients"



Don't miss an episode of “Power to the Patients” and subscribe to it in the GetPodcast app.








